OTC:PTIX | Free Cash Flow | Protagenic Therapeutics, Inc.\new

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-09-30 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30-$944,298.00
2026-03-31$265,533.00
2025-06-30-$1.75M
2025-03-31-$851,400.00
2024-12-31-$819,791.00
2024-03-31-$1.66M
2023-12-31-$1.14M
2023-03-31-$371,834.00
2022-12-31-$180,936.00
2022-03-31-$430,565.00
2021-12-31-$405,089.00
2021-03-31-$607,707.00
2020-12-31-$320,868.00
2020-03-31-$364,406.00
2019-12-31-$149,420.00
2019-03-31-$196,015.00
2018-12-31-$307,792.00
2018-03-31-$259,009.00
2017-12-31-$417,018.00
2017-03-31-$357,397.00
2016-12-31-$341,808.00
2016-03-31-$57,391.00
2015-12-31-$221,225.00
2015-09-30-$102,000.00
2015-06-30-$95,000.00$0.00-$95,000.00
2015-03-31-$9,001.00
2014-09-30-$80,000.00$0.00-$80,000.00
2014-06-30-$87,000.00$0.00-$87,000.00
2013-09-30-$436,000.00$1,000.00-$437,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.81M
2025-03-31-$1.77M
2024-12-31-$4.22M
2023-12-31-$3.7M
2022-12-31-$1.99M
2021-12-31-$2.8M
2020-12-31-$1.35M
2019-12-31-$487,990.00
2018-12-31-$1.07M
2017-12-31-$1.38M
2016-12-31-$1.14M
2015-12-31-$381,341.00$1,791.00-$383,132.00
2015-06-30-$378,000.00$1,000.00-$379,000.00
2014-06-30-$790,000.00$1,000.00-$791,000.00